The committee of experts followed their previous advice to recommend boosters of the Pfizer-BioNTech vaccine
so those who find themselves in high-risk settings have the option of getting an additional dose.)
Offit pointed out that regulators and public health officials haven’t made clear what the goal of the vaccine is. Originally, it appeared that vaccines were recommended to protect people from severe COVID-19 disease, but the push for boosters for everyone seems to shift the target toward preventing infection—which the vaccines are not as effective in doing, and wasn’t the standard by which they were initially tested.
Dr. Patrick Moore, another committee member and a professor at the University of Pittsburgh Cancer Institute, said he voted in favor of the booster “more from a gut feeling rather than based on really, truly serious data. The data itself is not strong, but [is] certainly going in the direction that is supportive of this vote.”
To provide context for the potential impact of booster doses, the committee also heard from experts from Israel, which was among the first countries to successfully vaccinate a large proportion of its adult population with the original two doses of Pfizer-BioNTech vaccine, and began seeing breakthrough infections among some of the older people who were vaccinated earliest. Israeli health officials authorized booster doses in August; Dr.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Independent FDA panel votes to authorize Moderna booster for seniors and high-risk AmericansBREAKING: An independent FDA advisory panel voted unanimously to authorize Moderna Covid-19 vaccine boosters for Americans 65 and older, anyone 18 and older with underlying conditions and those frequently exposed to the virus.
Lire la suite »
FDA Advisors Vote to Recommend Moderna BoostersA panel of experts that advises the FDA on vaccine decisions voted unanimously Thursday to approve booster doses of Moderna’s COVID-19 vaccine.
Lire la suite »
FDA vaccine advisers recommend emergency use authorization for booster dose of Moderna's Covid-19 vaccineVaccine advisers to the US Food and Drug Administration voted unanimously Thursday to recommend emergency use authorization of a booster dose of Moderna's Covid-19 vaccine.
Lire la suite »
FDA panel recommends Moderna booster for people over age 65The FDA Vaccines and Related Biological Products Advisory Committee voted in favor of recommending the emergency use authorization for the Moderna Covid-19 booster dose. The booster will be available for those 65 years and older, immune compromised and those with occupations that put them at risk for severe disease.
Lire la suite »
Moderna Booster Shot Backed by FDA Advisory PanelVaccine experts advising the Food and Drug Administration voted, 19-0, to recommend authorization of an extra dose of Moderna’s Covid-19 shot, a key step in making booster doses available to millions more people.
Lire la suite »
FDA panel unanimously endorses Moderna boosters for certain populationsMembers of the Food and Drug Administration’s vaccine expert panel on Thursday endorsed boosters for Moderna recipients who are at high risk of severe COVID-19, occupational exposure to COVID-19 or are 65 years and older.Why it matters: The unanimous decision mirrors the FDA conditions for those who qualify for a Pfizer booster.Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for freeBe smart: Despite small data sample sizes and limited data, the agency
Lire la suite »